From the Sector

Protective masks for Europe
With FleeceforEurope and Lindenpartner, Düsseldorf-based Kloepfel Group purchasing consultancy and Berlin-based industrial consultancy Bechinger & Heymann Holding plan to manufacture and distribute up to 50 million protection class FFP1 through FFP3 respiratory masks a month exclusively for the European market from the beginning of fall. And the primary focus will be on quality.
With protective masks – including those used in operating rooms – this quality is provided above all by  virus-absorbing nonwovens. And these will be manufactured by ‘FleeceforEurope’ using an Oerlikon Nonwoven meltblown system.
But masks effectively protecting against infections can only be guaranteed with the right quality. A crucial factor in this is the inside of the mask. Because the nonwoven used in protection class FFP1 through FFP3 respiratory masks plays a decisive role.
Here, the meltblown technology from Oerlikon Nonwoven will be deployed. In a special, patented process, the fibers laid into a nonwoven fabric during manufacture are subsequently electrostatically-charged, before the material is further processed downstream.

European market for protective masks with a promising future
Those responsible at Oerlikon Nonwoven and FleeceforEurope, which will primarily focus on producing high-end nonwovens, and Lindenpartner, which will manufacture and distribute the protective masks, are certain of one thing: the market for protective masks has a very promising long-term future in Europe.
What has been commonplace in Asia for many years now will also become normal in Europe. People will be increasingly wearing face masks when venturing out, in order to better protect themselves against health risks such as the current pandemic and also against increasing environmental pollution in the form of  fine particles and exhaust fumes in the future. A

Medical face masks from a vending machine
Mask producer Lindenpartner has already secured supplies of nonwovens and will be producing face masks for the European healthcare sector over the coming weeks. To fight the coronavirus pandemic, Lindenpartner is planning to install 100 self-service face mask vending machines in Germany over the next four weeks, positioning them in publicly-accessible places such as shopping centers and airports, for example.

Digitisation, Industry 4.0 and the expertise in this field should make fit for the working world of tomorrow. Nevertheless, these important topics are pushed into the back-ground in times of Corona. says ITA Academy ofefrs now online remote trainings for home-office: "Digital Transformation", the "Textile Summer School" and "Basics of Textile Technology"

The "Textile Summer School" will be held from 13 - 15 May and the training course "Basics of textile technology" from 28 - 30 July. They will impart expertise about the entire textile process chain. Starting with fibre science, through yarn and surface production to finishing and textile testing methods, all essential topics are cov-ered.
Both training courses are therefore suitable for interested employees and trainees from all areas of the company along the textile chain who wish to acquire or refresh specialist knowledge. This also gives lateral entrants and specialists with training from outside the indus-try the opportunity to enter the world of textiles more easily.

The "Textile Summer School" addresses both international and national customers. A good knowledge of English is required for participation. The course "Basics of Textile Technology" will be held in German.

In mid-March, CHT Germany GmbH, which specializes in specialty chemicals, took up production and distribution of hand disinfectant. Now the company is expanding its product portfolio by adding important medical supplies that can help fight Covid-19 (SARS-CoV-2). Starting immediately, CHT is providing its business customers with surface disinfectant, textile supplies for medical protective wear as well as supplies for test kits and face masks.

Following increased demand for disinfectant in the wake of the new coronavirus, the CHT Group began already a month and a half ago to produce hand disinfectant at its factory in Dußlingen. Since then, more of its factories around the world had joined in. Now the CHT Group is complementing this offering by producing its own surface disinfectant based on ethanol. As with the hand disinfectant, the production of the surface disinfectant received a special approval, based on the expanded general ruling by the German Federal Agency  for Chemicals (BAuA). Both types of disinfectant use publicly available standard formulas for alcohol-based disinfectant from the World Health Organization (WHO). The sale of CHT’s surface disinfectant, which is available in 5-, 10- and 30-liter canisters, is exclusively for use by industry customers.

In addition, the CHT Group is manufacturing a range of textile-relevant products that provide protection from Covid-19. These include functional supplies for face masks for medical protective wear, as well as flocking for test kits. Through these offerings, the CHT Group also wants to support the textile sector, which has been strongly affected by the crisis.

Staggered in terms of timing and with varying magnitude, the global spread of coronavirus is impacting the development of the regional economies in the core markets of the Manmade Fibers segment of the Swiss Oerlikon Group.
The sales markets for manmade fiber systems and equipment have been primarily located in China, India and Turkey for many years now. Together, these markets – above all China – make up the lion’s share of the project landscape at Oerlikon Manmade Fibers. And this is paying positive dividends at the moment. Because the production facilities of the major manmade fiber manufacturers in
China have been systematically fired up again over the past few weeks, with capacity utilization increasing consistently.

Going against the flow
The Segment CEO, Georg Stausberg explains the reason: “Long before the coronavirus situation developed, the major manmade fiber manufacturers in China had decided to reverse-integrate their production chains to include petrochemicals in order to expand their portfolios with targeted investments, to reduce their dependence on a ,single product’, to optimize their costs and ultimately to acquire greater control over margins in a global volume business”.
Similar processes and decisions – albeit not on the same scale as in China – have also
been detected at the large manmade fiber manufacturers in India and Turkey. Even though businesses in India and Turkey are presently still temporarily severely impacted by the coronavirus situation, their long-term commitment cannot however be questioned, as the company-internally-agreed plans will be systematically implemented moving forward.

Long-term investments of global market players
All this has recently resulted in increased demand for spinning and texturing systems – just like those supplied by total solutions provider Oerlikon Manmade Fibers with its
Oerlikon Barmag, Oerlikon Neumag and Oerlikon Nonwoven product brands.
“The investments in petrochemical systems are based on long-term strategic considerations and are resulting – even during the coronavirus pandemic – neither in short- and medium-term economic dips, nor in changed customer behavior. (...)”, states Segment-CEO Georg Stausberg.
As a result of Oerlikon Manmade Fibers delving into the digital age years ago, the segment has experienced the intensive and short-term benefit from all the measures, in part also in its processing of customer projects.

• All motions approved
• Dividend of CHF 4.50 agreed
• COVID-19

In relation to participation in the Annual General Meeting on April 16, 2020, the Board of Directors of Rieter Holding Ltd. arranged exclusively written or electronic voting and the granting of power of attorney to the independent proxy. In taking this approach, the Board of Directors relied on Article 6a, lit. b of Ordinance 2 of the Swiss Federal Council (Measures to Combat the Coronavirus of March 16, 2020). Physical participation by the shareholders was therefore not possible. The Annual General Meeting was held on the premises of Rieter Holding Ltd. at the company’s headquarters in Winterthur.

At the Annual General Meeting of Rieter Holding Ltd. on April 16, 2020, the independent proxy represented a total of 2 025 shareholders who hold 64.3% of the share capital.

A dividend of CHF 4.50 per share was agreed. The shareholders approved the proposed maximum total amounts of the remuneration of the members of the Board of Directors and of the Group Executive Committee for fiscal year 2021.

The Chairman of the Board, Bernhard Jucker, and the members of the Board of Directors This E. Schneider, Michael Pieper, Hans-Peter Schwald, Peter Spuhler, Roger Baillod, Carl Illi and Luc Tack were confirmed for an additional one-year term of office.
Furthermore, This E. Schneider, Hans-Peter Schwald and Bernhard Jucker, the members of the Remuneration Committee who were standing for election, were also each re-elected for a one-year term of office.

Shareholders also adopted all other motions proposed by the Board of Directors, namely approval of the annual report, the financial statements and the consolidated financial statements for 2019, and formal approval of the actions of the members of the Board of Directors and those of the Group Executive Committee in the year under review. In addition, the authorized capital was extended for a further two years.

COVID-19
At present, it is not possible to predict how the global COVID-19 pandemic will affect Rieter’s sales and earnings in the first and second half of 2020, and thus also for 2020 as a whole.

Rieter therefore refrains from providing an outlook for financial year 2020 and will issue the relevant information as part of the semi-annual report on July 16, 2020.
The company has taken the necessary measures to protect employees and to meet commitments to customers as far as possible.

Thanks to long-standing customer relationships, a focus on innovation, global positioning and the company’s financial stability, Rieter will successfully overcome the challenges.

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99 %.

Swiss company SANITIZED AG celebrates validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019).
Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2.

Patented technology featuring an ammonium silicate compound is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology. These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses.
The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Before a final product’s antiviral properties can be publicly promoted, viral tests must be performed in specialized laboratories. Compliance with local legal regulations is essential here. SANITIZED AG explicitly points out that this is standard procedure and has composed a preliminary Guide for Treating PPE

SANITIZED AG has been supporting the work of hygienists in hospitals, doctor’s offices, nursing and care facilities for many years with its antimicrobial - and now also antiviral - additives used to enhance the
functionality of textiles and polymers. The reduction of bacteria and viruses is a feasible way to help stem the spread of infections including MRSA.

a leading Asian large-scale manufacturer of manmade fibers and polymers has invested in a new Oerlikon Nonwoven meltblown system. The recently-signed contract comprises a 2-beam system for manufacturing filtration nonwovens – predominantly for medical products such as face masks – with a nominal capacity of up to 1,200 tons of nonwovens a year. The commercial production launch has been scheduled for the fourth quarter of 2020.

The 2-beam system has an operating width of 1.6 meters and is equipped with the new patented Oerlikon Nonwoven electro-charging unit. The Oerlikon Nonwoven meltblown technology is recognized by the market as being the technically most efficient method for producing highly-separating filter media made from manmade fibers, particularly in conjunction with electrostatic charging and with extremely low-pressure loss. Electro-charging the filter nonwovens allows the manufacture of sophisticated EPA- and HEPA-class filter media as well as media that comply with the requirements of N95-, FFP2- and FFP3-class respiratory masks.

The demand for filtration nonwovens for medical applications has risen tremendously across the globe since the outbreak of the Sars-CoV-2 (coronavirus) epidemic, presenting all manufacturers with huge challenges. A meltblown system will be commissioning at the site of a leading Western European nonwovens producers as early as the second quarter of 2020. This system will be deployed exclusively in the manufacture of nonwovens for respiratory masks.

Due to the current state of emergency with regards to the local supply of face masks, Oerlikon Nonwoven is currently using its own laboratory system to produce electrostatically-charged filter media which are being sent to local small businesses and companies for the manufacture of face masks. 

Brown Wrote to President Outlining Critical Steps White House can Take Now to Address Shortage of Personal Protective Equipment

 U.S. Sen. Sherrod Brown (D-OH) hosted a news conference call to discuss his plan for addressing the shortage of personal protective equipment (PPE) needed by healthcare workers on the frontline of keeping Americans healthy and safe during the coronavirus pandemic.

This weekend, Brown wrote to President Trump outlining several steps the Administration should take immediately to address the shortage and ramp up manufacturing of these critical medical supplies.

In his plan and in his letter to the President, Brown lists nine steps the Administration could take immediately, including:

1. Designate a government official who can serve as a point person responsible for coordination the acquisition and development of PPE, medical devices, and other supplies necessary to fight the coronavirus pandemic. 
2. Establish a PPE and medical device assessment and database to monitor the supply and anticipated needs for PPE, ventilators, diagnostic test kits, and other needed medical supplies to respond to the coronavirus pandemic. 
3. Publish a list of PPE, medical device, and general medical supply needs to respond to the coronavirus pandemic. 
4. Establish a hotline capable of handling significant call capacity that will provide U.S. producers centralized information about the results of the national assessment and the current need for PPE, devices, and other health care supplies. 
5. Provide immediate funding to manufacturers to purchase equipment, retool machinery, hire additional workers, and cover any other expenses needed to increase production of PPE and necessary medical devices and supplies.
6. Streamline contract and certification procedures to ensure production and delivery of materials are not delayed due to paperwork constraints.
7. Provide critical protections for workers who are making PPE, medical devices, and necessary supplies to receive a waiver from any shelter-in-place requirements to allow workers to volunteer to go to work in these critical industries. 
8. Provide purchase guarantees and delivery assistance of product to the communities and health care facilities that need the products most. 
9. Support companies that have the capacity to sterilize reusable equipment to alleviate the existing PPE shortage. 

In his plan, Brown also pointed out important legislative actions that will help ramp up production of these critical supplies, including expanding the strategic national stockpile authority, substantially increasing Defense Production Act funding and strengthening domestic preferences.

Textile innovator and specialty chemical producer Devan answers questions regarding anti-viral textile finish solutions following the growing spread of the COVID-19 outbreak.

Devan studied enveloped viruses (e.g. H1N1, Corona-types etc.) as well as naked viruses (e.g. Rotavirus). For both virus families BI-OME AV showed strong activity in wet state.
In the first instance, the company wants to focus on professionals who need to stay working such as policemen, logistics workers, shop employees, day-care workers.

A common complication of respiratory viral disease can be a secondary bacterial infection. Professionals could be helped with either an anti-bacterial on their facemask to reduce the chance for these secondary bacterial infections, for better hygiene and less odour build-up. On workwear, a combination of a virus spread reducing and antibacterial solution could help as these garments are typically used during long hours, are non-disposable and most likely will be washed at home.
 

HeiQ, winner of the Swiss Technology Award and Swiss Environmental Award, launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment that is tested effective against coronavirus.

Since its inception 15 years ago, HeiQ has forged a solid innovation track record helping brands improve textile products. Catalyzed to action by the global fight against Coronavirus, HeiQ launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment which is proven effective against human coronavirus (229E) in face mask testing, significantly enhancing the antiviral log reduction from 2.90 of untreated face masks to 4.48, over 99.99% reduction of virus infectivity. (Remarks: a log reduction of 2 is equivalent to 100 times the effectiveness).

Chinese protective masks producer Suzhou Bolisi is the lead adopter of HeiQ Viroblock NPJ03. Treated masks will be available on the market as early as this April. American legwear manufacturer Kayser-Roth is planning to add the technology to their new product, Ghluv hands protector, while Lufeng from China is evaluating the technology on other types of fabric used for garments.

HeiQ Viroblock NPJ03 is a unique combination of vesicle and silver technologies designed to inhibit the growth and persistence of bacteria and viruses. The HeiQ vesicle technology targets lipid- enveloped viruses, such as coronavirus, providing rapid virus deactivation, while the HeiQ silver technology inhibits the replication of both bacteria and viruses. HeiQ Viroblock NPJ03 can be applied to a wide spectrum of textile surfaces including face masks, air filters, medical gowns, curtains, drapes and more. HeiQ also has a range of highly wash-durable antimicrobial and odor control textile technologies, called HeiQ Pure, combining silver-based and bio-based materials for all fabric types.